Amy Del Medico: Hello, I’m Amy Del Medico and I’m Vice President of Ophthalmology here at Vial. I’m lucky enough to be talking today to Dr. Arshad Khanani and we’re g… Read More

A wide range of eye diseases and disorders can affect people of all ages. Luckily, advancements in ophthalmic drug development have provided effective treatment options. This article discuss… Read More

Highly effective injections for wet macular degeneration. Introduction How Successful are Injections for Wet Macular Degeneration Wet macular degeneration is a chronic eye condition that can… Read More

Currently, 30 antitrust cases are under investigation in the pharmaceutical sector The European Commission (EC) and EU national competition authorities (NCAs) together adopted 26 “int… Read More

What is Diabetic Retinopathy? Diabetes retinopathy is a type of eye disease caused by diabetes. Damage to the blood vessels of the light-sensitive tissue at the rear of the eye (retina) c… Read More

THE PHARMA MAJOR RECEIVED APPROVED FROM THE U.S Introduction: Pharma major lupin has received United States Food and Drug Administration (USFDA) approval for its new drug application f… Read More

According to Renub Research latest report, “Age-Related Macular Degeneration (AMD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Com… Read More

Diabetic retinopathy is a common complication of diabetes that affects the blood vessels in the retina, the light-sensitive tissue at the back of the eye. High blood sugar levels ca… Read More

Diabetic retinopathy is a serious eye condition caused by high blood sugar levels damaging the blood vessels in the retina, the light-sensitive tissue at the back of the eye. Diabet… Read More

Mumbai: Global Pharma major Lupin Limited has partnered with Amman Pharmaceuticals Industries, a pharmaceutical manufacturer with operations across the MENA region and other global markets… Read More

Intravitreal injections are a type of injection that delivers medication directly into the vitreous, the clear gel-like substance that fills the inside of the eye. These injections… Read More

Buy Now The United States Biosimilar market which currently has a market size of ~USD 9.48 Bn. is expected to grow at a CAGR of ~40% in the next five years and become a ~USD 96 Bn. industry… Read More

Biological drugs (sometimes known as ‘biologics’ or ‘biopharmaceuticals’) are drugs that are created by biological processes. They now target diseases that previously… Read More

The ‘Global Age-related macular degeneration (AMD) market Share, Size, Growth, Analysis, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook… Read More

Age-related macular degeneration Market (Albany, USA) DelveInsight’s “Age-related macular degeneration Market Insights, Epidemiology, and Market Forecast-2032” report… Read More

A study published in Ophthalmology Retina has concluded that XSB-001, administered every four weeks for managing nAMD patients, has equivalent efficacy to reference ranibizumab, as assessed… Read More

Introduction to the Top Pharma Companies in the World Top Pharma Companies in the World are leaders in the healthcare industry, recognized for their big product portfolios and contributions… Read More

The Anti-VEGF Market is a growing segment of the pharmaceutical industry that offers treatments for various eye diseases, including age-related macular degeneration (AMD), diabetic… Read More

Black spots in vision, also known as eye floaters, are tiny specks or threads that appear to float across your vision.  These small specks are caused by tiny clumps of gel or cells insi… Read More

According to Renub Research latest report, “Age-Related Macular Degeneration (AMD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Com… Read More

ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter   Weekly View February 24, 2023 From the desk of Priya Ranade… Read More

Biosimilar Contract Manufacturing Market Growth & Trends The global biosimilar contract manufacturing market size is expected to reach USD 25.7 billion by 2030, registering… Read More

Episode 6 of First in Human features Pravin Dugel, President at Iveric Bio. First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn… Read More

The ‘Global Age-related macular degeneration (AMD) market Size, Share, Growth, Analysis, Report and Forecast 2022-2027’ by Expert Market Research gives an extensive outlook of th… Read More

NEW YORK, NEW YORK – MAY 18: Hasan Minhaj and Beena Patel attend the 78th Annual Peabody Awards Ceremony Sponsored By Mercedes-Benz at Cipriani Wall Street on May 18, 2019 in New York… Read More

TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. announces that the European Commission (EC) has granted a Marketing Authorization for Ranivisio (ranibizuma… Read More

This article outlines six risks that threaten pharmaceutical manufacturers’ recovery from COVID-19 in 2020-21. In 2021, the pharmaceutical industry will likely recover from one of… Read More

Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the U.S. FDA has approved BYOOVIZ (ranibizumab-nuna), a biosimilar referencing LUCENTIS® (ranibizumab)i , for the treatment of ne… Read More

February 2022 | Report Format: Electronic (PDF) The global retinal implant market size is expected to reach USD 74.7 million by 2026, according to a new report by Grand View Research, Inc… Read More

Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for SB11, a proposed biosimilar r… Read More

Genentech’s ocular implant drug delivery system for treatment of macular degeneration has received approval from the US Food and Drug Administration (FDA). The system is called Susvimo… Read More

Market Synopsis Retinal biologics are bioengineered molecules that are implanted inside the eyes to heal chronic retinal diseases. There are a large number of different market player f… Read More

Rekabet Kurumu, ilaç şirketleri Roche ve Novartis’e Rekabetin Korunması Hakkında Kanun’un 4. maddesini ihlalden ceza kesti. Novartis Sağlık Gı… Read More

kalhh / Pixabay Pfizer to help manufacture Gilead’s remdesivir for COVID-19. Pfizer Inc. (NYC) on Friday said it inked a multiyear agreement to make COVID-19 treatment remdesivir for d… Read More